Xvivo Perfusion AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0004840718
SEK
271.60
7.6 (2.88%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
238.99
240.96
226.14
189.14
178.29
218.59
227.56
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
238.99
240.96
226.14
189.14
178.29
218.59
227.56
Raw Material Cost
87.87
87.49
79.77
63.23
61.61
74.05
88.29
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
3.14
10.43
40.62
0.00
Selling and Distribution Expenses
101.33
93.46
84.05
83.72
86.42
85.61
74.64
Other Expenses
2.78
2.86
2.52
2.07
1.36
-1.31
2.80
Total Expenditure (Excl Depreciation)
216.97
209.59
189.03
170.80
172.09
187.22
190.97
Operating Profit (PBDIT) excl Other Income
22
31.400000000000002
37.1
18.3
6.2
31.400000000000002
36.6
Other Income
10.71
11.46
4.08
-0.72
0.57
-1.60
34.14
Operating Profit (PBDIT)
52.70
61.96
60.46
35.61
23.31
46.17
107.15
Interest
0.00
0.00
0.00
3.14
10.43
40.62
0.00
Exceptional Items
0.00
0.00
0.00
0.30
0.31
-3.20
-21.11
Gross Profit (PBDT)
151.12
153.46
146.37
125.90
116.69
144.53
139.27
Depreciation
19.96
19.14
19.27
18.00
16.54
16.40
36.42
Profit Before Tax
32.73
42.83
41.19
14.77
-3.34
-14.05
49.62
Tax
16.45
6.53
9.54
10.43
-4.92
-1.65
13.23
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
16.28
36.30
31.65
4.34
1.57
-12.40
36.39
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
16.28
36.30
31.65
4.34
1.57
-12.40
36.39
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
16.28
36.30
31.65
4.34
1.57
-12.40
36.39
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
2,200.21
2,169.37
2,113.46
2,093.74
2,091.96
2,092.40
2,156.78
Earnings per share (EPS)
0.52
1.15
1.0
0.14
0.05
-0.39
1.15
Diluted Earnings per share
0.52
1.15
1.0
0.14
0.05
-0.39
1.15
Operating Profit Margin (Excl OI)
9.21%
13.02%
16.41%
9.69%
3.48%
14.35%
16.08%
Gross Profit Margin
22.05%
25.72%
26.74%
17.32%
7.4%
1.08%
37.81%
PAT Margin
6.81%
15.06%
14.0%
2.29%
0.88%
-5.67%
15.99%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2026 is 34.04% vs -15.22% in Jun 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2026 is 918.75% vs -94.12% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2026 is 85.02% vs -55.40% in Jun 2025

stock-summary

Interest

YoY Growth in quarter ended Jun 2026 is -100.00% vs 1,200.00% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Compare Quarterly Results Of Xvivo Perfusion AB With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Net Sales
238.99
385.00
-146.01
-37.92%
Other Operating Income
0.00
0.00
0.00
Total Operating income
238.99
385.00
-146.01
-37.92%
Raw Material Cost
87.87
143.00
-55.13
-38.55%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
101.33
181.00
-79.67
-44.02%
Other Expenses
2.78
4.30
-1.52
-35.35%
Total Expenditure (Excl Depreciation)
216.97
367.00
-150.03
-40.88%
Operating Profit (PBDIT) excl Other Income
22.02
18.00
4.02
22.33%
Other Income
10.71
8.00
2.71
33.88%
Operating Profit (PBDIT)
52.70
58.00
-5.30
-9.14%
Interest
0.00
0.00
0.00
Exceptional Items
0.00
-22.00
22.00
100.00%
Gross Profit (PBDT)
151.12
242.00
-90.88
-37.55%
Depreciation
19.96
32.00
-12.04
-37.62%
Profit Before Tax
32.73
4.00
28.73
718.25%
Tax
16.45
0.00
16.45
Provisions and contingencies
0
0
0.00
Profit After Tax
16.28
4.00
12.28
307.00%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
16.28
4.00
12.28
307.00%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
16.28
4.00
12.28
307.00%
Equity Capital
0
0
0.00
Face Value
0.00
1.39
0.00
Reserves
2,200.21
3,846.00
-1,645.79
-42.79%
Earnings per share (EPS)
0.52
0.05
0.47
940.00%
Diluted Earnings per share
0.52
0.05
0.47
940.00%
Operating Profit Margin (Excl OI)
9.21%
4.68%
0.00
4.53%
Gross Profit Margin
22.05%
9.35%
0.00
12.70%
PAT Margin
6.81%
1.04%
0.00
5.77%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 23.90 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -0.83% vs 6.59% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 34.04% vs -15.22% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.63 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -55.10% vs 14.87% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 918.75% vs -94.12% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.20 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -16.83% vs -10.46% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 85.02% vs -55.40% in Jun 2025

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.21%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025